T1	Pharmacological_substance 9 24	D-penicillamine
N1000 	Reference T1 MeSH:D010396	D-penicillamine
T2	Disorder 33 62	crescentic glomerulonephritis
N1 	Reference T2 UMLS:C0403416	crescentic glomerulonephritis
T3	Disorder 127 138	scleroderma
N2 	Reference T3 UMLS:C0011644	scleroderma
T4	Disorder 169 187	glomerulonephritis
N3 	Reference T4 UMLS:C0017658	glomerulonephritis
T5	Disorder 230 240	hemoptysis
N4 	Reference T5 UMLS:C0019079	hemoptysis
T6	Pharmacological_substance 260 275	D-penicillamine
N1001 	Reference T6 MeSH:D010396	D-penicillamine
T7	Disorder 318 331	Renal failure
N5 	Reference T7 UMLS:C0035078	Renal failure
T8	Pharmacological_substance 370 385	D-penicillamine
N1002 	Reference T8 MeSH:D010396	D-penicillamine
T9	Pharmacological_substance 404 419	glucocorticoids
N1003 	Reference T9 MeSH:D005938	glucocorticoids
T10	Pharmacological_substance 434 446	azathioprine
N1004 	Reference T10 MeSH:D001379	azathioprine
T11	Pharmacological_substance 526 541	D-penicillamine
N1005 	Reference T11 MeSH:D010396	D-penicillamine
T12	Disorder 570 588	glomerulonephritis
N6 	Reference T12 UMLS:C0017658	glomerulonephritis
T13	Pharmacological_substance 712 729	immunosuppressive
N1006 	Reference T13 MeSH:D007166	immunosuppressive
T15	Subject 104 121	56-year-old woman
T18	Combination 420 428	combined
T19	Disorder 468 494	recovery of renal function
T21	Manner_cue 550 557	rapidly
T23	Subject 660 680	5 untreated patients
T24	Subject 695 705	5 patients
T26	Disorder 681 685	died
N7 	Reference T26 UMLS:C1546956	died
N8 	Reference T26 UMLS:C1306577	died
T27	Disorder 742 747	alive
N9 	Reference T27 UMLS:C2584946	alive
T29	Disorder 193 213	epithelial crescents
N10 	Reference T29 UMLS:C0405479	epithelial crescents
